'Stage ii' diaporamas de présentation

1.19k views • 81 slides

Safe Sedation for patients with special needs

Safe Sedation for patients with special needs. Dr John M LOW MA. (Oxford University) BM.BCh . (Oxford University) FRCA. , FHKCA. , FANZCA., FHKAM .( Anaesthesiology ) Partner, Dr. Roger Hung and Partners. Overview. Achieving sympatholysis Sedation vs General Anaesthesia

966 views • 81 slides

Adjuvante therapie van het coloncarcinoom anno 2004-2005: is 5FU/LV nog steeds de standaard?

Adjuvante therapie van het coloncarcinoom anno 2004-2005: is 5FU/LV nog steeds de standaard?. Prof.dr. C.J.A. Punt afd. Medische Oncologie UMC St. Radboud Nijmegen. Adjuvant therapy for colon cancer hot topics 2004. FOLFOX Capecitabine Stage II Primary endpoint in randomised studies.

631 views • 51 slides

875 views • 47 slides

More approximation algorithms for stochastic programming programs

686 views • 46 slides

Recent progress of the KISS project at KEK-WNSC

505 views • 43 slides

Axel Grothey Professor of Oncology Mayo Clinic, Rochester, Minnesota, USA

Axel Grothey Professor of Oncology Mayo Clinic, Rochester, Minnesota, USA. Vice Chair and Director of Cancer Treatment of the North Central Cancer Treatment Group (NCCTG) Co-chair of the gastrointestinal program of NCCTG

584 views • 43 slides

Prof Sanjay Patole, MD, DCH, FRACP, MSc, DrPH Centre for Neonatal Research and Education

Ad vances in necrotising enterocolitis. Prof Sanjay Patole, MD, DCH, FRACP, MSc, DrPH Centre for Neonatal Research and Education KEM Hospital for Women, University of Western Australia, Perth. Necrotising enterocolitis in preterm neonates.

1.21k views • 39 slides

FRIENDSHIP

426 views • 39 slides

an Endcap TOF and TRD for Identifying electrons at EIC

an Endcap TOF and TRD for Identifying electrons at EIC.

331 views • 24 slides

Adjuvant therapy for stage II colon cancer: where are we now?

Adjuvant therapy for stage II colon cancer: where are we now?. Professor Werner Scheithauer University of Vienna Vienna, Austria. Healthcare providers. Treatment costs. Resource use. Factors that may influence adjuvant treatment decisions. Patient characteristics. Biomarkers.

568 views • 21 slides

New Zealand National Poisons Centre

New Zealand National Poisons Centre. IRON OVERDOSE. IRON. In healthy adults ~ 2 to 10% of dietary iron absorbed In iron deficiency states (including children) 80 to 90% is absorbed

327 views • 20 slides

Mei Xu , Jamie Wolff and Michelle Harrold National Center for Atmospheric Research (NCAR)

7B.7 Inter-comparison of AFWA Operational Configurations using WRFv3.3.1 and WRFv3.4. Mei Xu , Jamie Wolff and Michelle Harrold National Center for Atmospheric Research (NCAR) Research Applications Laboratory (RAL) and Developmental Testbed Center (DTC). AFWA Configuration Testing.

320 views • 19 slides

Mei Xu , Jamie Wolff and Michelle Harrold National Center for Atmospheric Research (NCAR)

7B.7 Inter-comparison of AFWA Operational Configurations using WRFv3.3.1 and WRFv3.4. Mei Xu , Jamie Wolff and Michelle Harrold National Center for Atmospheric Research (NCAR) Research Applications Laboratory (RAL) and Developmental Testbed Center (DTC). AFWA Configuration Testing.

326 views • 19 slides

Management of Vulval Cancer Services in South West England

Management of Vulval Cancer Services in South West England. Jenny Weeks J Verne L Hirschowitz, V Udaysanker, AD Falconer on behalf SWCIS Gynaecology Tumour Panel. September 2004. SWIS Gynaecology Tumour Panel. 4 Cancer Networks. Multidisciplinary membership. 3 Counties. ASWCS.

1.09k views • 18 slides

Kidney Cancer Treatment

Kidney Cancer Treatment

231 views • 10 slides

220 views • 7 slides

Fatigue striation morphology

420 views • 6 slides

133 views • 4 slides

Gene cluster

Gene cluster. 1. 2. 3. Stage I. Stage II. Stage III/IV. A549. NCI-H460, EKVX, HOP-92, NCI-H226, HOP-62.

113 views • 1 slides